Codexis (CDXS) grants director 66,350 stock options at $2.48

Rhea-AI Filing Summary

CODEXIS, INC. director Stephen George Dilly reported receiving a grant of stock options. The award covers 66,350 options to buy Common Stock at an exercise price of $2.48 per share, with 66,350 derivative securities shown as held after the transaction.

These options were granted as compensation, not bought on the open market, and carry no upfront cost to the director. They vest and become exercisable for all shares on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, provided he continues serving as a director through that vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DILLY STEPHEN GEORGE

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	66,350	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 66,350 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 66,350 options Exercise price: $2.48 per share Expiration date: June 17, 2036 +1 more

4 metrics

Options granted 66,350 options Stock Option (Right to Buy) grant to director

Exercise price $2.48 per share Exercise price for Codexis common stock under the option

Expiration date June 17, 2036 Option expiration for the director grant

Derivative securities held after 66,350 derivative securities Total options shown following this transaction

Key Terms

Stock Option (Right to Buy), exercise price, annual stockholder meeting

3 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 2.4800"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

annual stockholder meeting financial

"earlier of the first anniversary of the date of grant or the next annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DILLY STEPHEN GEORGE

(Last) (First) (Middle)

C/O CODEXIS, INC.

200 PENOBSCOT DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.48	06/17/2026		A		66,350		(1)	06/17/2036	Common Stock	66,350	$0	66,350	D

Explanation of Responses:

1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

	/s/ Georgia Erbez, as Attorney-in-Fact for Stephen G. Dilly	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Codexis (CDXS) director Stephen Dilly report in this Form 4?

Director Stephen George Dilly reported receiving a grant of stock options in Codexis, Inc. The award is a compensation-related grant, not an open-market share purchase or sale, and provides the right to buy Codexis common stock at a fixed exercise price.

How many Codexis (CDXS) stock options were granted to the director?

The director was granted options covering 66,350 shares of Codexis common stock. After this grant, the filing shows 66,350 derivative securities held, all tied to this award, giving him the right to acquire an equivalent number of common shares upon exercise.

What is the exercise price and term of the Codexis (CDXS) options?

The options have an exercise price of $2.48 per share and expire on June 17, 2036. This means the director can choose to buy Codexis common stock at $2.48 up until that expiration date, once the options have vested.

When do the Codexis (CDXS) director options vest?

The options vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting. Vesting is conditional on the director’s continued service to Codexis through that vesting date, according to the footnote disclosure.

Is this Codexis (CDXS) Form 4 a stock purchase or sale?

This Form 4 reflects a grant of stock options, not a market purchase or sale of shares. The director acquired the right to buy Codexis stock in the future at a set price as part of his director compensation package.

How many Codexis (CDXS) derivative securities does the director hold after this grant?

Following the transaction, the filing shows the director holding 66,350 derivative securities related to this option award. These represent rights to acquire 66,350 shares of Codexis common stock upon exercise after vesting, subject to the award’s terms.